VA Documents Reveal Schedule III Cannabis Policy for Veterans

VA Guidance Maintains Federal Prescription Ban

Rescheduling cannabis to Schedule III won't permit VA doctors to prescribe or recommend marijuana to veterans. Federal employees remain prohibited from facilitating cannabis access under 38 U.S.C. § 7332 and the Controlled Substances Act, regardless of scheduling tier, according to the internal guidance.

The policy framework distinguishes between Schedule III reclassification and authorization for federal medical use. VA physicians may discuss cannabis with patients. But they can't provide written recommendations, referrals to state programs, or documentation for medical marijuana cards.

Documentation and Benefits Impact

Veterans using state-legal cannabis won't face benefits penalties or care denials under the new guidance. The VA directive instructs clinicians to document cannabis use in patient records without triggering disciplinary action or program disqualification.

Key protections outlined in the documents include:

• No denial of VA healthcare services based on cannabis use
• Continued eligibility for pain management programs
• No referral to substance abuse treatment solely for state-legal cannabis consumption
• Protection from veterans benefits reduction or termination

This guidance doesn't extend to veterans in states without medical cannabis programs or to recreational use outside state-legal frameworks.

Research and Clinical Trial Implications

Schedule III status will streamline VA-sponsored cannabis research by reducing DEA licensing barriers for clinical trials. The documents reference 21 CFR § 1301.18, which governs research registration for Schedule III substances and imposes fewer restrictions than Schedule I protocols.

VA researchers won't need separate DEA Schedule I licenses to conduct cannabis studies. According to the guidance, the agency has three active Investigational New Drug applications pending FDA review for veteran PTSD and chronic pain trials. Rescheduling is expected to accelerate enrollment timelines by an estimated four to six months per study.

State Program Coordination Gaps

The VA documents don't establish formal coordination mechanisms with state medical marijuana programs. Veterans seeking cannabis recommendations must obtain them from non-VA physicians, and the agency won't reimburse costs for state program enrollment, physician consultations, or cannabis products.

According to the guidance, 33 states include PTSD as a qualifying condition for medical cannabis, but VA clinicians can't certify veterans for those programs. This creates a care gap for veterans in rural areas with limited access to private physicians willing to provide cannabis recommendations.

For comprehensive background on federal rescheduling, see the CannIntel topic hub on DEA Schedule III rescheduling.

We'll be watching VA Secretary testimony before the Senate Veterans Affairs Committee on June 12, 2026, where cannabis policy is expected to be addressed.